Skip to content

To investigate the clinical application value of LncRNA-H19 in elderly diabetic osteoporosis based on dual-energy X-ray

To investigate the clinical application value of LncRNA-H19 in elderly diabetic osteoporosis based on dual-energy X-ray

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074807
Enrollment
Unknown
Registered
2023-08-16
Start date
2023-05-20
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic osteoporosis

Interventions

Simple type 2 diabetes group:N/A
Diabetes with osteoporosis:N/A

Sponsors

The First People's Hospital of Lianyungang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for type 2 diabetes established by the World Health Organization (WHO) in 1999;(2) The bone mineral density of the patients was determined by whole-body dual-energy X-ray bone densitometer, which was in line with the diagnostic criteria for osteoporosis formulated by WHO in 1994.(3) = 50 years old;(4) All enrolled patients were approved by the Ethics Committee and signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Type 1 diabetes; (2) Acute complications of diabetes, such as ketoacidosis. (3) Patients with acute and chronic infectious diseases. (4) Other endocrine system diseases that may affect bone metabolism, such as hyperthyroidism, hyperparathyroidism, autoimmune diseases, Cushing syndrome, etc. (5) Recent use of steroid hormones, vitamin D, calcium preparations and other drugs that interfere with bone metabolism. (6) Patients who have been diagnosed with osteoporosis and have started drug therapy. (7) Tumor patients. (8) Have a fondness for alcohol and tobacco. (9) serious insufficiency of heart, kidney, liver and other organs. (10) Patients who need to stay in bed for a long time for various reasons. (11) unnatural menopause (such as patients after hysterectomy and adnexectomy).

Design outcomes

Primary

MeasureTime frame
Long non-coding RNA H19;Serum TGF-ß1;

Secondary

MeasureTime frame
bone mineral density;

Countries

China

Contacts

Public ContactWang Guofeng

The First People's Hospital of Lianyungang

nfmwangguofeng@126.com+86 189 6132 7083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026